Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas

[1]  Brigitta G. Baumert,et al.  Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma , 2016, The Lancet. Oncology.

[2]  J. Debus,et al.  Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma , 2016, Strahlentherapie und Onkologie.

[3]  Walter J. Curran,et al.  Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. , 2016, The New England journal of medicine.

[4]  J. Olson,et al.  The role of initial chemotherapy for the treatment of adults with diffuse low grade glioma , 2015, Journal of Neuro-Oncology.

[5]  D. Brat,et al.  Management of patients with recurrence of diffuse low grade glioma , 2015, Journal of Neuro-Oncology.

[6]  J. Olson,et al.  The role of biopsy in the management of patients with presumed diffuse low grade glioma , 2015, Journal of Neuro-Oncology.

[7]  J. Olson,et al.  The role of neuropathology in the management of patients with diffuse low grade glioma , 2015, Journal of Neuro-Oncology.

[8]  J. Olson,et al.  The role of surgery in the management of patients with diffuse low grade glioma , 2015, Journal of Neuro-Oncology.

[9]  M. Hellmich,et al.  Stereotactic interstitial brachytherapy for the treatment of oligodendroglial brain tumors , 2015, Strahlentherapie und Onkologie.

[10]  A. Olar,et al.  Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification. , 2015, Seminars in radiation oncology.

[11]  W. Curry,et al.  Proton therapy for low‐grade gliomas: Results from a prospective trial , 2015, Cancer.

[12]  J. Huse,et al.  The Evolving Molecular Genetics of Low-grade Glioma , 2015, Advances in anatomic pathology.

[13]  H. Colman,et al.  Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas. , 2015, Neurosurgical focus.

[14]  J. Tonn,et al.  Personalized surgical therapy. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  C. Belka,et al.  Iodine-125 brachytherapy for brain tumours - a review , 2012, Radiation Oncology.

[16]  V. Sturm,et al.  Stereotactic brachytherapy of low-grade cerebral glioma after tumor resection. , 2011, Neuro-oncology.

[17]  Mitchel S Berger,et al.  Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article. , 2011, Journal of neurosurgery.

[18]  R Grant,et al.  Guidelines on management of low‐grade gliomas: report of an EFNS–EANO * Task Force , 2010, European journal of neurology.

[19]  M. Ruge,et al.  Surgical resection plus stereotactic 125I brachytherapy in adult patients with eloquently located supratentorial WHO grade II glioma – Feasibility and outcome of a combined local treatment concept , 2008, Journal of Neurology.

[20]  Susan M. Chang,et al.  Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  M. Faist,et al.  Interstitial 125I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults , 2006, Cancer.

[22]  A. Muacevic,et al.  Long term course of WHO grade II astrocytomas of the Insula of Reil after I-125 interstitial irradiation , 2004, Journal of neurology.

[23]  M. Berger,et al.  Stereotactic Radiosurgery and Interstitial Brachytherapy for Glial Neoplasms , 2004, Journal of Neuro-Oncology.

[24]  K. Hoang-Xuan,et al.  Recommendations for the management of adult patients with intracranial glioma ( 2002 ) , 2022 .

[25]  Desmond Curran,et al.  Prognostic factors for survival in adult patients with cerebral low-grade glioma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  M. Faist,et al.  The risk of interstitial radiotherapy of low-grade gliomas. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  M. Faist,et al.  Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas , 1997, Cancer.

[28]  M. Faist,et al.  Interstitial radiosurgery of low-grade gliomas , 1995 .

[29]  P. Wen,et al.  Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. , 1995, Neurosurgery.

[30]  M. Berger,et al.  The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas , 1994, Cancer.

[31]  M. Bernstein,et al.  Intracranial arterial occlusion associated with high-activity iodine-125 brachytherapy for glioblastoma , 1993, Journal of Neuro-Oncology.

[32]  Y. Shibamoto,et al.  Supratentorial low‐grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variables , 1993, Cancer.

[33]  B. Meyer,et al.  [Not Available]. , 2016, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[34]  J. Olson,et al.  The role of radiotherapy in the management of patients with diffuse low grade glioma , 2015, Journal of Neuro-Oncology.

[35]  F. Kreth,et al.  The place of interstitial brachytherapy and radiosurgery for low-grade gliomas. , 2010, Advances and technical standards in neurosurgery.

[36]  C. Ostertag,et al.  Iodine-125 interstitial irradiation for cerebral gliomas , 2005, Acta Neurochirurgica.

[37]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[38]  M. Berger,et al.  Functional mapping-guided resection of low-grade gliomas. , 1995, Clinical neurosurgery.

[39]  M. Malkin,et al.  Relationship of the patterns of recurrence to the technical accuracy of stereotactic interstitial implantation for high grade gliomas , 1991 .

[40]  E. Howard.  [Not Available]. , 1946, Revista medica.